SlideShare a Scribd company logo
Anchoring latent scale values for the EQ-5D-Y
at 0 = dead
Koonal Shah1,2, Juan Manel Ramos-Goñi3, Simone Kreimeier4, Nancy Devlin1,2
[1] Office of Health Economics, UK
[2] University of Sheffield, UK
[3] EuroQol Office, Netherlands
[4] Bielefeld University, Germany
EuHEA Maastricht
13 July 2018
This study was funded by the EuroQol
Research Foundation. The views expressed are
those of the authors and not necessarily those
of the EuroQol Research Foundation.
EuHEA, July 2018 | SHAH
2
EQ-5D-Y: state of play
• EQ-5D-Y – ‘youth’ version of the EQ-5D
• Use is modest but growing
• No values sets available to support its use in economic evaluation
• Recent research has indicated that regular EQ-5D-3L value sets cannot be
used for children and adolescents
• Concerns exist around the use of TTO to value the health of children
EuHEA, July 2018 | SHAH
3
EQ-5D-Y instrument
EuHEA, July 2018 | SHAH
4
Latent scale DCE (adult)
EuHEA, July 2018 | SHAH
5
Latent scale DCE (adolescent)
EuHEA, July 2018 | SHAH
6
• Aims:
• To compare the use of alternative methods for establishing anchors
• To generate evidence to support the anchoring of UK latent scale DCE data
• To compare anchors for the EQ-5D-3L and EQ-5D-Y
• Computer-assisted personal interviews (n=350)
• Respondents answered questions both about their own health (using
EQ-5D-3L) and about the health of a 10 year old child (using EQ-5D-Y)
• Two-arm design: random half of sample started with adult questions and
proceeded to child questions; ordering was reversed for the other half
Anchoring study
EuHEA, July 2018 | SHAH
7
Study design
1. Introduction and warm-up questions
2. Ranking
(adult)
3. VAS
(adult)
4. TTO
(adult)
5. DCE with
duration
(adult)
6. Location of dead
tasks based on PUF
method (adult)
7. Half-way point – perspective switch
13. Debrief and background questions
8. Ranking
(child)
9. VAS
(child)
10. TTO
(child)
11. DCE with
duration
(child)
12. Location of dead
tasks based on PUF
method (child)
EuHEA, July 2018 | SHAH
8
VAS – rating of 33333 and ‘Dead’
EuHEA, July 2018 | SHAH
9
(Lag-time) TTO – valuation of 22222 and 33333
EuHEA, July 2018 | SHAH
10
DCE with duration – seven paired comparison tasks
EuHEA, July 2018 | SHAH
11
Location of dead – up to five tasks
EuHEA, July 2018 | SHAH
12
Deducing the region in which dead is located
EuHEA, July 2018 | SHAH
13
Results
• All four methods show that the observed/predicted/estimated values (or
rescaled ratings, in the case of VAS) for 33333 were higher, on average,
under a child health perspective than under an adult health perspective
Adult perspective Child perspective
VAS -0.04 +0.07
TTO -0.37 -0.03
DCE -0.80 +0.06
LOD -0.50 -0.36
EuHEA, July 2018 | SHAH
14
Results – valuation of 33333 in relation to dead
EuHEA, July 2018 | SHAH
15
Responses to debrief questions
EuHEA, July 2018 | SHAH
16
Criteria for selecting a preferred anchoring method
• Feasibility
• Acceptability to decision makers
• Potential for administration online
• Theoretical and empirical coherence with the preference
data to be anchored
• Theoretical and empirical coherence with the methods for
valuing adult health
EuHEA, July 2018 | SHAH
17
Thank you for listening
To enquire about additional information and analyses, please contact Koonal Shah at
kshah@ohe.org
To keep up with the latest news and research, subscribe to our blog, OHE News
Follow us on Twitter @OHENews, LinkedIn and SlideShare
Office of Health Economics (OHE)
Southside, 7th Floor
105 Victoria Street
London SW1E 6QT
United Kingdom
+44 20 7747 8850
www.ohe.org
OHE’s publications may be downloaded free of charge from our website.

More Related Content

PPTX
Koonal's Slides from the 2017 PROMs Conference
PDF
New Methods for Analysing the Distribution of 5Q 5D Observations
PPTX
Top 5 things anatomy educators need to know about learning analytics
PPTX
Is uw instelling klaar voor learning analytics?
KEY
Abstracts & Conferences
PDF
AISH Bulletin Apr 2007
PPTX
Valuing the EQ-5D-Y Principles, methods and current research
PPTX
Developing a value set for the EQ-5D-Y to support its use in HTA
Koonal's Slides from the 2017 PROMs Conference
New Methods for Analysing the Distribution of 5Q 5D Observations
Top 5 things anatomy educators need to know about learning analytics
Is uw instelling klaar voor learning analytics?
Abstracts & Conferences
AISH Bulletin Apr 2007
Valuing the EQ-5D-Y Principles, methods and current research
Developing a value set for the EQ-5D-Y to support its use in HTA

Similar to Anchoring latent scale values for the EQ-5D-Y at 0 = dead (20)

PPTX
Valuing paediatric preference-based measures: using a discrete choice experim...
PPTX
Generating preference-based values for the EQ-5D-Y to support its use in HTA
PDF
1000 Minds Poster
PPTX
A new method for valuing quality of life: Direct elicitation of personal util...
PDF
ISoQOL poster - PUF 2015
PPTX
A Comparison of Three EQ-5D Value sets
PPTX
EuroQol Scientific Agenda Sept2012 Devlin
PPTX
An EQ-5D-5L Value Set for England- Nancy Devlin and Ben Van Hout
PPTX
Application of EQ-5D in Reimbursement Decision Making: The Case of NICE
PPTX
Fundamentals of Health Economics - Final Presentation.pptx
PPTX
Adjusting for Differential Item Functioning in the EQ-5D-5L Using Externally-...
PDF
Adjusting for Differential Item Functioning in the EQ-5D-5L Using Externally-...
PDF
Seminar on Studies about Valuing End-of-Life Health Care
PDF
OHE_ seminar_5L_value_set_Oct2014
PPTX
The EQ-5D and Its Use Internationally
PPTX
Niek Klazinga | Performance reporting in OECD countries
PPTX
AHP Unscheduled Care Event 2019 (Morning Session)
PDF
Valuing Health at the End of Life: Defining Public Preferences
PPTX
Cadth 2015 e3 eq5 d
Valuing paediatric preference-based measures: using a discrete choice experim...
Generating preference-based values for the EQ-5D-Y to support its use in HTA
1000 Minds Poster
A new method for valuing quality of life: Direct elicitation of personal util...
ISoQOL poster - PUF 2015
A Comparison of Three EQ-5D Value sets
EuroQol Scientific Agenda Sept2012 Devlin
An EQ-5D-5L Value Set for England- Nancy Devlin and Ben Van Hout
Application of EQ-5D in Reimbursement Decision Making: The Case of NICE
Fundamentals of Health Economics - Final Presentation.pptx
Adjusting for Differential Item Functioning in the EQ-5D-5L Using Externally-...
Adjusting for Differential Item Functioning in the EQ-5D-5L Using Externally-...
Seminar on Studies about Valuing End-of-Life Health Care
OHE_ seminar_5L_value_set_Oct2014
The EQ-5D and Its Use Internationally
Niek Klazinga | Performance reporting in OECD countries
AHP Unscheduled Care Event 2019 (Morning Session)
Valuing Health at the End of Life: Defining Public Preferences
Cadth 2015 e3 eq5 d
Ad

More from Office of Health Economics (20)

PPTX
PPTX
Devlin ispor 2020 issues panel 20.05.20
PDF
Towse 2020 antimicrobials melbourne final
PDF
Towse cgd price transparency seminar
PPTX
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
PPTX
Pricing in emerging markets: options to get value for money - Adrian Towse
PPTX
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
PPTX
The role of real world data and evidence in building a sustainable & efficien...
PDF
ISPOR Education Symposium- Go where the money is
PDF
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
PDF
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
PDF
Ispor 2019 poster - Patricia Cubi-Molla
PDF
Understanding what aspects of health and quality of life are important to people
PDF
Novel approaches for valuing health at the end of life
PDF
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
PDF
HTA and payment mechanisms for new drugs to tackle AMR
PDF
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
PDF
Pay for Performance for Specialised Care in England
PDF
Real option value drugs: is it really an option?
PDF
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
Devlin ispor 2020 issues panel 20.05.20
Towse 2020 antimicrobials melbourne final
Towse cgd price transparency seminar
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian Towse
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
The role of real world data and evidence in building a sustainable & efficien...
ISPOR Education Symposium- Go where the money is
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
Ispor 2019 poster - Patricia Cubi-Molla
Understanding what aspects of health and quality of life are important to people
Novel approaches for valuing health at the end of life
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
HTA and payment mechanisms for new drugs to tackle AMR
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Pay for Performance for Specialised Care in England
Real option value drugs: is it really an option?
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
Ad

Recently uploaded (20)

PDF
Transcultural that can help you someday.
PPTX
Clinical approach and Radiotherapy principles.pptx
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PPTX
History and examination of abdomen, & pelvis .pptx
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPTX
vertigo topics for undergraduate ,mbbs/md/fcps
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PPTX
Spontaneous Subarachinoid Haemorrhage. Ppt
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
regulatory aspects for Bulk manufacturing
PPTX
Acid Base Disorders educational power point.pptx
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPTX
antibiotics rational use of antibiotics.pptx
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PDF
Hemostasis, Bleeding and Blood Transfusion.pdf
Transcultural that can help you someday.
Clinical approach and Radiotherapy principles.pptx
Obstructive sleep apnea in orthodontics treatment
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
CHEM421 - Biochemistry (Chapter 1 - Introduction)
History and examination of abdomen, & pelvis .pptx
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
vertigo topics for undergraduate ,mbbs/md/fcps
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
Spontaneous Subarachinoid Haemorrhage. Ppt
OPIOID ANALGESICS AND THEIR IMPLICATIONS
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
surgery guide for USMLE step 2-part 1.pptx
regulatory aspects for Bulk manufacturing
Acid Base Disorders educational power point.pptx
MENTAL HEALTH - NOTES.ppt for nursing students
Electrolyte Disturbance in Paediatric - Nitthi.pptx
antibiotics rational use of antibiotics.pptx
focused on the development and application of glycoHILIC, pepHILIC, and comm...
Hemostasis, Bleeding and Blood Transfusion.pdf

Anchoring latent scale values for the EQ-5D-Y at 0 = dead

  • 1. Anchoring latent scale values for the EQ-5D-Y at 0 = dead Koonal Shah1,2, Juan Manel Ramos-Goñi3, Simone Kreimeier4, Nancy Devlin1,2 [1] Office of Health Economics, UK [2] University of Sheffield, UK [3] EuroQol Office, Netherlands [4] Bielefeld University, Germany EuHEA Maastricht 13 July 2018 This study was funded by the EuroQol Research Foundation. The views expressed are those of the authors and not necessarily those of the EuroQol Research Foundation.
  • 2. EuHEA, July 2018 | SHAH 2 EQ-5D-Y: state of play • EQ-5D-Y – ‘youth’ version of the EQ-5D • Use is modest but growing • No values sets available to support its use in economic evaluation • Recent research has indicated that regular EQ-5D-3L value sets cannot be used for children and adolescents • Concerns exist around the use of TTO to value the health of children
  • 3. EuHEA, July 2018 | SHAH 3 EQ-5D-Y instrument
  • 4. EuHEA, July 2018 | SHAH 4 Latent scale DCE (adult)
  • 5. EuHEA, July 2018 | SHAH 5 Latent scale DCE (adolescent)
  • 6. EuHEA, July 2018 | SHAH 6 • Aims: • To compare the use of alternative methods for establishing anchors • To generate evidence to support the anchoring of UK latent scale DCE data • To compare anchors for the EQ-5D-3L and EQ-5D-Y • Computer-assisted personal interviews (n=350) • Respondents answered questions both about their own health (using EQ-5D-3L) and about the health of a 10 year old child (using EQ-5D-Y) • Two-arm design: random half of sample started with adult questions and proceeded to child questions; ordering was reversed for the other half Anchoring study
  • 7. EuHEA, July 2018 | SHAH 7 Study design 1. Introduction and warm-up questions 2. Ranking (adult) 3. VAS (adult) 4. TTO (adult) 5. DCE with duration (adult) 6. Location of dead tasks based on PUF method (adult) 7. Half-way point – perspective switch 13. Debrief and background questions 8. Ranking (child) 9. VAS (child) 10. TTO (child) 11. DCE with duration (child) 12. Location of dead tasks based on PUF method (child)
  • 8. EuHEA, July 2018 | SHAH 8 VAS – rating of 33333 and ‘Dead’
  • 9. EuHEA, July 2018 | SHAH 9 (Lag-time) TTO – valuation of 22222 and 33333
  • 10. EuHEA, July 2018 | SHAH 10 DCE with duration – seven paired comparison tasks
  • 11. EuHEA, July 2018 | SHAH 11 Location of dead – up to five tasks
  • 12. EuHEA, July 2018 | SHAH 12 Deducing the region in which dead is located
  • 13. EuHEA, July 2018 | SHAH 13 Results • All four methods show that the observed/predicted/estimated values (or rescaled ratings, in the case of VAS) for 33333 were higher, on average, under a child health perspective than under an adult health perspective Adult perspective Child perspective VAS -0.04 +0.07 TTO -0.37 -0.03 DCE -0.80 +0.06 LOD -0.50 -0.36
  • 14. EuHEA, July 2018 | SHAH 14 Results – valuation of 33333 in relation to dead
  • 15. EuHEA, July 2018 | SHAH 15 Responses to debrief questions
  • 16. EuHEA, July 2018 | SHAH 16 Criteria for selecting a preferred anchoring method • Feasibility • Acceptability to decision makers • Potential for administration online • Theoretical and empirical coherence with the preference data to be anchored • Theoretical and empirical coherence with the methods for valuing adult health
  • 17. EuHEA, July 2018 | SHAH 17 Thank you for listening To enquire about additional information and analyses, please contact Koonal Shah at kshah@ohe.org To keep up with the latest news and research, subscribe to our blog, OHE News Follow us on Twitter @OHENews, LinkedIn and SlideShare Office of Health Economics (OHE) Southside, 7th Floor 105 Victoria Street London SW1E 6QT United Kingdom +44 20 7747 8850 www.ohe.org OHE’s publications may be downloaded free of charge from our website.